CCS vs ECG
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Aug 01, 2026
CCS
ECG
Investment Advisor Scores
ECG
AI Analyst Insights
Detailed Metrics Comparison
| Metric | CCS | ECG | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 18.6567 | 26.2467 | CCS |
| PEG Ratio | 0.45 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -7.3% | 25.4% | ECG |
| Earnings Growth | 10.5% | 58.7% | ECG |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 55.5/100 | 53.5/100 | CCS |
| Profit Margin | 3.4% | 5.7% | ECG |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
CCS
MarkupPrice above SMA50, rising 50-day trend (8.3% over 20 days), RSI 52
ECG
MarkdownPrice below a falling SMA50 (slope -5.0%), weak momentum, RSI 43
Fundamentals Snapshot
| Metric | CCS | ECG |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 14.6 | 24.5 |
| Trailing P/E | 15.3 | 25.0 |
| Revenue (TTM) | — | — |
| Revenue Growth | -0.1% | 0.3% |
| Gross Margin | 0.2% | 0.1% |
| Operating Margin | 0.1% | 0.1% |
| EPS | 4.48 | 4.92 |
| Dividend Yield | 0.02% | — |